A double‐blind randomized placebo‐controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression

Acta Psychiatrica Scandinavica - Tập 94 Số 6 - Trang 404-410 - 1996
J. E. De Wilde1, S. Geerts2, Jan Van Dorpe3, Jacques Bruhwyler4, Joseph Géczy4
1Neuropsychiatric Clinic, St Camillus, Sint-Denijs-Westrem, Belgium.
2St Lucas Clinic, Assebroek, Belgium
3A.Z. Heilig Hart, Asse, Belgium
4Therabel Research S.A., Brussels, Belgium

Tóm tắt

The efficacy and safety of pirlindole (300 mg/day), a new reversible inhibitor of monoamine oxidase A, have been evaluated in a multicentre placebo‐controlled double‐blind randomized trial in 103 in‐patients suffering from unipolar major depression (DSM‐III‐R 296.2, 296.3) over a 42‐day period after a run‐in placebo period of 6 days. Pirlindole produced a significantly greater decrease than placebo in the Hamilton depression score (from day 28), the Hamilton anxiety score (from day 28) and the Montgomery‐Asberg depression score (on day 42). On day 42, the Hamilton depression score was ≤ 7, ≥8 and ≤15, or ≥16 in 21 %, 45% and 34%, respectively, in the placebo group compared to 72%, 24% and 3.4%, respectively, in the pirlindole group (P < 0.001). The differences between the two groups in terms of tolerance and safety were not statistically significant.

Từ khóa


Tài liệu tham khảo

10.1111/j.1600-0447.1994.tb01530.x

10.1192/S0007125000297523

Davis JM, 1985, Comprehensive textbook of psychiatry, 1513

McGrath PJ, 1986, Phenelzine treatment of melancholia, J Clin Psychiatry, 47, 420

Laux G, 1990, Clinical, biochemical and psychometric findings with the new MAO‐A inhibitors moclobemide and brofaromine in patients with major depressive disorder, J Neural Transm, 32, 189

10.1016/0304-3940(85)90501-4

10.1111/j.1600-0447.1990.tb05348.x

10.1016/0278-5846(93)90054-V

10.1055/s-2007-1017421

10.1192/bjp.160.4.519

10.1007/BF02246248

Martorana PA, 1979, The new antidepressant pirlindole: a comparison with imipramine and tranylcypromine, Arzncim Forsch Drug Res, 29, 946

Mashkovsky MD, 1981, Pharmacological properties of 2,3,3a,4,5,6‐hexahydro‐8‐methyl‐lH‐pyrazino [3,2,1‐j,k] carbazol hydrochloride (Pirlindole), a new antidepressant, Arzneim Forsch Drug Res, 31, 75

Maj J, 1986, Central action of the antidepressant drug pirlindole, Arzneim Forsch Drug Res, 36, 1198

Schraven VE, 1984, Hemmung der Monoaminoxidase A und B in Herz und Gehirn von Ratten durch Amitriptylin, Pargylin und Pirlindol, Arzneim Forsch Drug Res, 34, 1258

Pöldinger W., 1983, Psychiatry. The state of the art. Vol. 3. Pharmacopsychiatry, 283

Saletu B, 1983, Psychiatry. The state of the art. Vol. 3. Pharmacopsychiatry, 291

Schäpperle O, 1983, Psychiatry. The state of the art. Vol. 3. Pharmacopsychiatry, 297

Renfordt E., 1983, Psychiatry. The state of the art. Vol. 3. Pharmacopsychiatry, 311

Blaha L., 1983, Psychiatry. The state of the art. Vol. 3. Pharmacopsychiatry, 303

Lehmann E, 1983, Psychiatry. The state of the art. Vol. 3. Pharmacopsychiatry, 321

10.1007/BF02246245

Danish University Antidepressant Group., 1986, Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicentre study, Psychopharmacology, 90, 131

10.1007/BF02246251

Schwarz JA, 1983, Psychiatry. The state of the art. Vol. 3. Pharmacopsychiatry, 233

Stabl M, 1989, Review of comparative clinical trials. Moclobemide vs. tricyclic antidepressants and vs. placebo in depressive states, J Neural Transm, 28, 77

Thông tin
Thông tin xuất bản

Acta Psychiatrica Scandinavica

Tập 94 Số 6

404-410

Thông tin tác giả